Description:
Unlock the insights into the burgeoning field of molecular point of care (mPOC) with Kalorama Information’s comprehensive report, The Market and Future Potential for Molecular Point of Care (POC), 2023. This essential resource delves into the significant growth and opportunities within the mPOC market, providing critical data and analysis for industry professionals and businesses.
Overview:
Molecular point of care testing has evolved from a novel trend to a major market player, significantly contributing to the in vitro diagnostics (IVD) POC sector. Leading companies like Abbott, BioMérieux, and Cepheid, along with numerous emerging competitors, are driving this transformation. Understanding this market is crucial for grasping the full scope of opportunities in point of care testing and microbiology IVD.
Key Highlights:
- Market Sizing and Forecasting: Detailed market size estimates and growth forecasts from 2022 to 2027.
- Competitive Analysis: Insights into current market leaders, including market share by vendor for both the molecular and near-patient segments.
- Trend Mapping: Analysis of key trends, such as the impact of COVID-19 testing, menu expansion, and emerging markets.
- Geographic Breakout: Comprehensive breakdown of the molecular POC market across North America, Europe, Asia-Pacific, and the rest of the world.
- Segment Analysis: Examination of various market segments, including respiratory versus other applications, with specific breakdowns for flu, RSV, strep, and other respiratory conditions.
Comprehensive Coverage:
- Market Opportunities: Explore the potential beyond COVID-19 and identify new growth areas.
- Systems and Consumables: Detailed analysis of current systems on the market and the competitive landscape.
- Vendor Analysis: Market share data for leading vendors in both the molecular and near-patient molecular IVD markets.
- Company Profiles: In-depth profiles of key companies driving innovation and growth in the mPOC market.
Unique Insights:
Kalorama Information provides unique dual perspectives on near-patient molecular testing using small instruments and molecular point-of-care systems. This dual approach ensures the report is valuable for a wide range of business planning needs.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Near Patient Molecular Systems Market, 2022-2027 (in millions $)
| Year | Revenues ($M) | Growth |
| 2022 | $XX Million | XX% |
| 2023 | $XX Million | XX% |
| 2024 | $XX Million | XX% |
| 2025 | $XX Million | XX% |
| 2026 | $XX Million | XX% |
| 2027 | $XX Million | XX% |
| CAGR | $XX Million | XX% |
Source: Kalorama Information
